Determinatin of Aldose Reductase (AR) activity in Diabetic Patients

Authors

  • Ferah Ghali Al-Salihi
  • Ayaat Jasim Mohammed

DOI:

https://doi.org/10.25130/tjps.v21i5.1033

Abstract

The current study included estimation of Aldose reductase (AR) activity in serum of diabetic  patients. The study included (47) samples of seram from  diabetic patients serum (both types I and II), the patients age ranged from (9-80) years old, and (36) samples of seram from healthy people (control group) aged between (12-80) years old. The results showed significant elevation (P <0.05) in the AR activity in diabetic patients for both types compared with control group. The AR activity was (38.65 ±9.60) IU/ L in the serum of type II diabetes patients and (29.52 ± 5.75) IU/ L in patients with type I diabetes, compared to (11.01 ± 2.19) IU/ L in the serum of healthy people

Downloads

Published

2023-02-06

How to Cite

Ferah Ghali Al-Salihi, & Ayaat Jasim Mohammed. (2023). Determinatin of Aldose Reductase (AR) activity in Diabetic Patients. Tikrit Journal of Pure Science, 21(5), 88–92. https://doi.org/10.25130/tjps.v21i5.1033

Issue

Section

Articles